Knudsen; Lotte Bjerre

Patent Applications and Registrations

Patent applications and USPTO patent grants for Knudsen; Lotte Bjerre.The latest application filed is for "glp-1 receptor agonists in dementia".

Company Profile

0.3.13

Knudsen; Lotte Bjerre - Jerslev DK
Knudsen; Lotte Bjerre - Valby DK
Knudsen; Lotte Bjerre - Kalundborg DK

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Glp-1 Receptor Agonists In Dementia App 20220280612 - Friedrich; Sarah ; et al.	2022-09-08
Novel Compounds For Treatment Of Obesity App 20210261641 - Roed; Nikolaj Kulahin ; et al.	2021-08-26
Use of GLP-1 compound for treatment of critically ill patients Grant 8,088,731 - Knudsen , et al. January 3, 2	2012-01-03
Use Of Glp-1 Compound For Treatment Of Critically Ill Patients App 20100311651 - Knudsen; Lotte Bjerre ; et al.	2010-12-09
Combined Use Of A GLP-1 Compound And A Modulator Of Diabetic Late Complications App 20100184690 - Knudsen; Lotte Bjerre ; et al.	2010-07-22
Use of Ghrelin Antagonists to the Treatment of Certain CNS Diseases App 20090149512 - Raun; Kirsten ; et al.	2009-06-11
Combined use of a GLP-1 compound and another drug for treating dyslipidemia App 20070207964 - Knudsen; Lotte Bjerre ; et al.	2007-09-06
Combined use of a GLP-1 compound and a modulator of diabetic late complications App 20070167373 - Knudsen; Lotte Bjerre ; et al.	2007-07-19
Use of GLP-1 compound for treatment of critically ill patients App 20060229248 - Knudsen; Lotte Bjerre ; et al.	2006-10-12
Combined use of a GLP-1 compound and another drug for treating dyslipidemia App 20050256053 - Knudsen, Lotte Bjerre ; et al.	2005-11-17
Combined use of a GLP-1 compound and another drug for treating dyslipidemia Grant 6,939,853 - Knudsen , et al. September 6, 2	2005-09-06
Combination treatment using exendins and thiazolidinediones App 20040180824 - Knudsen, Lotte Bjerre	2004-09-16
Use of GLP-1 compound for treatment of critically ill patients App 20030199445 - Knudsen, Lotte Bjerre ; et al.	2003-10-23
Glucagon antagonists/inverse agonists Grant 6,613,942 - Ling , et al. September 2, 2	2003-09-02
Combined use of a GLP-1 compound and another drug for treating dyslipidemia App 20030143183 - Knudsen, Lotte Bjerre ; et al.	2003-07-31
Combined use of a GLP-1 compound and modulator of diabetic late complications App 20030144206 - Knudsen, Lotte Bjerre ; et al.	2003-07-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.